Essayer OR - Gratuit
Future-ready, innovation driven enterprise in API intermediates
Ingredients South Asia
|January 1-15, 2026
Sichuan Dingke Pharmaceutical Co., Ltd. is a young, ambitious enterprise founded in 2022.
-
Company Identity and Heritage
The company, which participated in API China 2025, aims to redefine the landscape of API intermediates, pharmaceutical chemicals, and advanced cosmetic ingredients. Despite its recent establishment, Dingke Pharma is closely associated with one of China's most respected traditional medicine groups, a parent organisation boasting more than 300 years of brand heritage. This unique association provides the company with a deep foundation in scientific wisdom, regulatory understanding, and proven excellence in Chinese medicinal science. The company's sales efforts are led by Maggie Liu, sales director.
Manufacturing and Infrastructure Excellence
The company began its manufacturing operations recently, utilising a state-of-the-art facility that reflects world-class pharmaceutical engineering standards.
Modern Design: The plant is designed with high automation, modern environmental controls, and stringent safety systems.
Cette histoire est tirée de l'édition January 1-15, 2026 de Ingredients South Asia.
Abonnez-vous à Magzter GOLD pour accéder à des milliers d'histoires premium sélectionnées et à plus de 9 000 magazines et journaux.
Déjà abonné ? Se connecter
PLUS D'HISTOIRES DE Ingredients South Asia
Ingredients South Asia
Sustainability becoming cornerstone of cosmetics industry
There has been an incredible shift in cosmetics over the last few decades.
5 mins
January 1-15, 2026
Ingredients South Asia
"We mostly relied on customer funding to grow"
Greenspace Herbs, a leading botanical ingredients company is gearing up for its commercial launch of Quantum Ayurveda, an advanced technology platform that enhances traditional herbal ingredients using quantum resonance principles. For us innovation represents the first successful commercialisation of quantum-enhanced botanical supplements, bridging ancient Ayurvedic wisdom with cutting-edge scientific methodology, said SHAFIULLA NURUDDIN HIREHAL, director, Greenspace Herbs, in an email interaction with NANDITA VIJAYASIMHA. Excerpts:
6 mins
January 1-15, 2026
Ingredients South Asia
Harmonisation moving toward regulatory alignment
AFRICA stands out as a highly attractive frontier for pharmaceutical growth, fueled by rapid population expansion, a rising disease burden, and increasing demand for high-quality healthcare solutions.
4 mins
January 1-15, 2026
Ingredients South Asia
Increasing penetration of clean-label, natural ingredients
The food ingredients sector plays a pivotal role in the global food and beverages value chain, providing essential components that enhance taste, texture, nutrition, safety, and shelf life of food products.
3 mins
January 1-15, 2026
Ingredients South Asia
India's expertise can fill critical gaps in Africa
AFRICA'S demand for medicines is rising faster than almost anywhere else in the world. Population growth, urbanisation and the steady increase in noncommunicable diseases such as diabetes, cardiovascular conditions and cancer are reshaping pharmaceutical consumption. As African governments expand health-insurance coverage and essential-medicine lists, public procurement of medicines is increasing sharply across the continent. Yet Africa's pharmaceutical ingredients sector remains overwhelmingly import-dependent, with more than 95% of active pharmaceutical ingredients (APIs) sourced from Asia. The Covid-19 pandemic exposed the fragility of this model, as global supply disruptions translated into local shortages. Combined with the rising burden of communicable and noncommunicable diseases, these pressures have elevated API manufacturing from a longstanding policy aspiration to a strategic public-health and economic priority.
4 mins
January 1-15, 2026
Ingredients South Asia
Industry to discuss APIs scheme with Korea to attract investment
IN a major boost to the Indian bulk drugs industry, Indian pharma industry and exporters will discuss the production linked incentive (PLI) scheme for active pharmaceutical ingredients (APIs) with the Korean pharma industry at the upcoming 16th Edition of KOREA PHARM & BIO 2026 to attract Korean investment into India's pharmaceutical and API sector. Besides this, opportunities for business partnerships and collaborations will also be discussed.
2 mins
January 1-15, 2026
Ingredients South Asia
India gains ground in excipients globally: Sinha
INDIA is gaining ground as a reliable excipient supplier globally as Indian manufacturers are adding capacity and improving regulatory compliance.
1 min
January 1-15, 2026
Ingredients South Asia
Future-ready, innovation driven enterprise in API intermediates
Sichuan Dingke Pharmaceutical Co., Ltd. is a young, ambitious enterprise founded in 2022.
2 mins
January 1-15, 2026
Ingredients South Asia
DoP extends timeline for submission under PLI scheme
THE Department of Pharmaceuticals (DOP) has extended the timeline for the industry to submit their applications for support under the production linked incentive (PLI) scheme for bulk drugs to produce key ingredients of broad-spectrum carbapenem antibiotic meropenem and antiretroviral drug ritonavir.
2 mins
January 1-15, 2026
Ingredients South Asia
Ministry issues draft amendment to remove cough syrups from Schedule K
THE Union health ministry has proposed an amendment to remove cough syrups from Schedule K, to make its sales strictly under prescription of a medical practitioner.
1 mins
January 1-15, 2026
Listen
Translate
Change font size